Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:bicyclo[2.2.2]octane-2,6-dione
go back to main search page
Accession:CHEBI:87404 term browser browse the term
Definition:An alicyclic ketone that is bicyclo[2.2.2]octane carrying two oxo groups located at positions 2 and 6.
Synonyms:related_synonym: Formula=C8H10O2;   InChI=1S/C8H10O2/c9-7-3-5-1-2-6(7)8(10)4-5/h5-6H,1-4H2;   InChIKey=VXBMHPUAHFEJAV-UHFFFAOYSA-N;   SMILES=O=C1CC2CCC1C(=O)C2
 xref: PMID:17198383;   Reaxys:2247740


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 844
    chemical entity 844
      molecular entity 842
        polyatomic entity 806
          molecule 700
            cyclic compound 619
              polycyclic compound 306
                bridged compound 0
                  bicyclo[2.2.2]octane-2,6-dione 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 844
    subatomic particle 828
      composite particle 828
        hadron 828
          baryon 828
            nucleon 828
              atomic nucleus 828
                atom 828
                  main group element atom 816
                    p-block element atom 813
                      carbon group element atom 784
                        carbon atom 780
                          organic molecular entity 780
                            organic group 360
                              organic divalent group 358
                                organodiyl group 358
                                  carbonyl group 357
                                    carbonyl compound 357
                                      ketone 168
                                        cyclic ketone 152
                                          alicyclic ketone 4
                                            bicyclo[2.2.2]octane-2,6-dione 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.